Blythe is a health economist and pharmacoepidemiologist serving as principal quantitative scientist at Flatiron Health. She designs comparative-effectiveness studies, codes mathematical models of disease progression, and oversees academic research science. Her objective is to learn from the experience of real-world patients and generate evidence to understand the value of new medicines using electronic health record-derived data.
Dr. Adamson is a researcher with experience at the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Institute for Disease Modeling, Intellectual Ventures and Boston Scientific. She is a leader in the International Society for Health Economics and Outcomes Research (ISPOR).
She received her PhD in pharmaceutical science and MPH in epidemiology from the University of Washington. Dr. Adamson enjoys writing about the economics of infectious diseases at www.blytheadamson.com.